GPR35 and cancer: Cell proliferation following GPR35 knockdown was significantly reduced across a range of cancer cell lines representing intestinal (Caco-2 and SW480), liver (HepG2), pancreatic (Capan-2) and breast (MCF-7) epithelial cells (Fig. 4A).